ZURICHRoche Holding AG said Monday it was buying Danish biopharmaceutical firm Santaris Pharma for as much  million as the Swiss giant looks for ways to develop drugs for diseases difficult to address with existing medicines Roche based in Basel Switzerland said in a statement that it would make an initial cash payment of  million for privately held Santaris which specializes in relatively new RNAtargeting therapeutics Roche will make additional payments of as much as  million if the company reaches certain
  